Orazio Vittorio

Dr. Orazio Vittorio

Children's Cancer Institute, University of New South Wales, Kensington NSW 2750, Australia
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Cancer Research
Verified
Journal Article
Closed access
PDF file
FVFlorida Voli
Florida Voli
EVEmanuele Valli
Emanuele Valli
LLLuigi Lerra
Luigi Lerra
KKKathleen Kimpton
Kathleen Kimpton
FSfederica saletta
federica saletta
Orazio VittorioOrazio Vittorio
Orazio Vittorio
Therapeutic checkpoint antibodies blocking programmed death receptor 1/programmed death ligand 1 (PD-L1) signaling have radically improved clinical outcomes in cancer. However, the regulation of PD-L1 expression on tumor cells is still poorly understood. Here we show that intratumoral copper levels influence PD-L1 expression in cancer cells. Deep analysis of the The Cancer Genome Atlas database and tissue microarrays showed strong correlation between the major copper influx transporter copper transporter 1 (CTR-1) and PD-L1 expression across many cancers but not in corresponding normal tissues. Copper supplementation enhanced PD-L1 expression at mRNA and protein levels in cancer cells and RNA sequencing revealed that copper regulates key signaling pathways mediating PD-L1–driven cancer immune evasion. Conversely, copper chelators inhibited phosphorylation of STAT3 and EGFR and promoted ubiquitin-mediated degradation of PD-L1. Copper-chelating drugs also significantly increased the number of tumor-infiltrating CD8+ T and natural killer cells, slowed tumor growth, and improved mouse survival. Overall, this study reveals an important role for copper in regulating PD-L1 and suggests that anticancer immunotherapy might be enhanced by pharmacologically reducing intratumor copper levels. Significance: These findings characterize the role of copper in modulating PD-L1 expression and contributing to cancer immune evasion, highlighting the potential for repurposing copper chelators as enhancers of antitumor immunity.

21 December 2009 in Nanomedicine
Verified
Journal Article
Closed access
RVRaffa Vittoria
Raffa Vittoria
GCGianni Ciofani
Gianni Ciofani
Orazio VittorioOrazio Vittorio
Orazio Vittorio
CRCristina Riggio
Cristina Riggio
ACAlfred Cuschieri
Alfred Cuschieri
Carbon nanotubes (CNTs) are widely used for biomedical applications as intracellular transporters of biomolecules owing to their ability to cross cell membranes. In this article, we survey the reported literature and results of our published work in an attempt to provide a rational view of the various CNT internalization mechanisms. Essentially three uptake mechanisms (phagocytosis, diffusion and endocytosis) have been reported in the literature. In addressing the subject of cellular internalization of CNTs, the unique physicochemical characteristics of CNTs that influence and drive the cell uptake pathway are considered. According to available evidence, the degree of dispersion, the formation of supramolecular complexes and the nanotube length are crucial factors in determining the exact mechanism of cellular uptake. In conclusion, phagocytosis appears to be the internalization pathway for CNT aggregates, bundles, cluster or single dispersed nanotubes 1 microm or more in length; endocytosis is the internalization mechanism for nanotubes forming supramolecular structures; and diffusion is the internalization mechanism for submicron CNTs that do not form supramolecular complexes. This information may be relevant to the rational design of CNT-based carriers for cell therapy.

19 January 2016 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
SOSusan Oliver
Susan Oliver
Orazio VittorioOrazio Vittorio
Orazio Vittorio
Giuseppe CirilloGiuseppe Cirillo
Giuseppe Cirillo
Cyrille BoyerCyrille Boyer
Cyrille Boyer
Well-known for their antioxidant properties, polyphenols are naturally occurring compounds containing one or more phenol groups. A high dietary intake of polyphenols has been linked to a reduced incidence of a number of diseases, including cancer, cardiovascular diseases, diabetes, osteoporosis and neurodegenerative diseases. Furthermore, in vitro and in vivo studies show the potential for polyphenols as therapeutic agents with cardioprotective, antimicrobial, anticancer, neuroprotective, and antidiabetic effects demonstrated. Despite their impressive therapeutic effects, polyphenols suffer from a number of drawbacks, including instability when exposed to light, heat and basic conditions; poor bioavailability; rapid metabolism; and poor membrane permeability. These drawbacks limit the clinical applications of polyphenols. Polymers and other macromolecules are well-known for their ability to stabilise and improve the bioavailability of therapeutic agents. A number of macromolecular systems have been developed that stabilise polyphenols whilst enhancing their therapeutic effects, including direct polymerisation of polyphenol monomers via step-growth, free radical and enzyme catalysed reactions; and conjugation with macromolecules via enzyme grafting, free-radical grafting, esterification and amidation. In this review, we will detail the key techniques employed to stabilise polyphenols with macromolecules and provide examples of each technique.

1 December 2009 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
Orazio VittorioOrazio Vittorio
Orazio Vittorio
RVRaffa Vittoria
Raffa Vittoria
ACAlfred Cuschieri
Alfred Cuschieri

24 June 2013 in Critical Reviews in Food Science and Nutrition
Verified
Journal Article
Closed access
Giuseppe CirilloGiuseppe Cirillo
Giuseppe Cirillo
Manuela CurcioManuela Curcio
Manuela Curcio
Orazio VittorioOrazio Vittorio
Orazio Vittorio
FIFrancesca Iemma
Francesca Iemma
DRDonatella Restuccia
Donatella Restuccia
NPNevio Picci
Nevio Picci
In recent years, antioxidants have gained great importance because of their potential use in food, pharmaceutical, and cosmetic industries. This interest is rooted in the cumulative evidence connecting active oxygen and free radicals with numerous human degenerative disorders, such as cardiovascular diseases, cancer, aging, and atherosclerosis. Polyphenols are the major class of antioxidant able to reduce the oxidative damages of lipids, proteins, enzymes, carbohydrates, and DNA in living cells and tissues. Among the realm of polyphenol compounds, polyphenol conjugates have been proposed as innovative materials which, by combining the advantageous properties of both the components, can increase the efficiency of antioxidants and their range of application in nutritional and biomedical fields. This work is an overview of the different class of polyphenol conjugates, which will be analyzed in terms of nutritional and biological properties, showing how these bio-conjugates will positively affect the human health.

1 March 2017 in Biomaterials
Verified
Journal Article
Closed access
LKLeoni Kunz-Schughart
Leoni Kunz-Schughart
Anna DubrovskaAnna Dubrovska
Anna Dubrovska
CPClaudia Peitzsch
Claudia Peitzsch
AEAlexander Ewe
Alexander Ewe
AAAchim Aigner
Achim Aigner
SPSuman Pokhrel
Suman Pokhrel